Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats

Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats

ABSTRACT Background Insulin‐treated diabetic cats frequently achieve transient remission. The glucagon‐like peptide‐1 receptor agonist, exenatide extended‐release (exenatide‐ER), preserves β cell function in people with type 2 diabetes mellitus (DM). Objectives Investigate the effect of exenatide‐ER...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen Gilor, Linda M. Fleeman, Sean E. Hulsebosch, Stijn J. M. Niessen, Charlotte R. Bjørnvad, Jully Pires, Katarina Hazuchova, Jocelyn Mott, Allison L. O'Kell, Ruth Gostelow, Adam J. Rudinsky, Audrey K. Cook
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Journal of Veterinary Internal Medicine
Subjects:
diabetes mellitus
feline
GLP‐1
glucagon
remission
weight loss
Online Access:https://doi.org/10.1111/jvim.70069
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/jvim.70069

Similar Items